TipRanks
Go Ultimate55% OFF

Wockhardt Limited (WOCKPHARMA) Price & Analysis

WOCKPHARMA Stock Chart & Stats

₹1,896.10-₹25.35(-1.32%)
At close: 4:00 PM EDT
INR 1,800INR 2,000INR 2,2003 Aug17 Aug31 Aug15 Sep28 Sep12 Oct26 Oct
Day’s Range
INR 1,868.60 - INR 1,929.90
52-Week Range
INR 1,086.80 - INR 2,420.00
Previous Close
INR 1,921.45
Volume
236.67K
Average Volume (3M)
59.98K
Market Cap
INR 308.09B
Enterprise Value
INR 210.41B
Total Cash (Recent Filing)
INR 6.80B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
75.6
Beta
1.32
Next Earnings
Nov 02, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

The return to steady revenue growth indicates improving demand and commercial execution across Wockhardt’s pharmaceutical portfolio. Continued top-line expansion can support operating leverage, strengthen reinvestment capacity, and provide a more durable base for earnings recovery over the next several quarters.

Return To Profitability

Positive net income marks a meaningful recovery from prior losses and demonstrates that the business can again convert its operations into accounting earnings. If maintained, profitability should improve internal funding capacity and reinforce the company’s ability to invest in products, capabilities, and market access.

Balance-Sheet Cushion

Stable debt alongside a larger equity base improves financial cushioning and reduces the relative burden of leverage on the business. This gives Wockhardt greater resilience while it rebuilds profitability, supporting continued investment and providing more flexibility to manage operating volatility.

Bears Say

Prolonged Earnings Volatility

Several years of losses show that the recent recovery has not yet established a consistently profitable operating model. This history raises the risk that earnings could weaken again if business conditions deteriorate, making long-term performance less predictable and limiting confidence in sustained compounding.

Volatile Operating Profitability

Large swings in EBIT indicate that margins have not yet demonstrated durable stability across reporting periods. Such variability can make earnings sensitive to product mix and operating conditions, complicate planning, and reduce the reliability of profits available for reinvestment or debt servicing.

Uneven Cash Conversion

Modest and inconsistent free cash flow indicates that reported earnings do not always translate into cash available for shareholders or reinvestment. Persistently uneven conversion can constrain funding flexibility, increase reliance on balance-sheet resources, and make the recovery less durable than net income alone suggests.

Wockhardt Limited News

WOCKPHARMA FAQ

What was Wockhardt Limited’s price range in the past 12 months?
Wockhardt Limited lowest stock price was ₹1086.80 and its highest was ₹2420.00 in the past 12 months.
What is Wockhardt Limited’s market cap?
Wockhardt Limited’s market cap is ₹308.09B.
When is Wockhardt Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wockhardt Limited’s earnings last quarter?
Wockhardt Limited released its earnings results on Aug 10, 2026. The company reported ₹6.523 earnings per share for the quarter.
Is Wockhardt Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Wockhardt Limited pay dividends?
Wockhardt Limited pays a Notavailable dividend of ₹9.218 which represents an annual dividend yield of ―. See more information on Wockhardt Limited dividends here
What is Wockhardt Limited’s EPS estimate?
Wockhardt Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wockhardt Limited have?
Wockhardt Limited has 162,485,570 shares outstanding.
What happened to Wockhardt Limited’s price movement after its last earnings report?
Wockhardt Limited reported an EPS of ₹6.523 in its last earnings report. Following the earnings report the stock price went down -4.36%.
Which hedge fund is a major shareholder of Wockhardt Limited?
Currently, no hedge funds are holding shares in IN:WOCKPHARMA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology